We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Reversine Causes Cell Regression

By Biotechdaily staff writers
Posted on 15 Jan 2004
Researchers seeking multipotent stem cells from non-embryonic sources have identified a small synthetic molecule that can induce cells to undergo dedifferentiation to regress developmentally from their current state to form their own precursor cells. More...


Investigators at the Scripps Research Institute (La Jolla, CA, USA; www.scripps.edu) reported in the December 19, 2003, online edition of the Journal of the American Chemical Society that muscle cells growing in tissue culture reverted to multipotent precursor cells (stem cells) after treatment with the compound reversine. The effect of reversine on these mammalian cells may be similar to the situation in lower animals that are able to regenerate limbs or tails that have been severed or to that in the liver, the only human organ capable of regeneration.

"This has the potential to make stem cell research more practical,” explained senior author Dr. Sheng Ding, assistant professor of chemistry at the Scripps Research Institute. "This will allow you to derive stem-like cells from your own mature cells, avoiding the technical and ethical issues associated with embryonic stem cells. This may ultimately facilitate development of small molecule therapeutics for stimulating the body's own regeneration.”




Related Links:
Scripps Research Institute

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.